Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations

被引:82
|
作者
Fothergill, Joanne L. [1 ,2 ]
Mowat, Eilidh [2 ]
Ledson, Martin J. [3 ]
Walshaw, Martin J. [3 ]
Winstanley, Craig [1 ,2 ]
机构
[1] Royal Liverpool Univ Hosp, Biomed Res Ctr, Liverpool L69 3GA, Merseyside, England
[2] Univ Liverpool, Sch Infect & Host Def, Div Med Microbiol, Liverpool L69 3GA, Merseyside, England
[3] Liverpool Heart & Chest Hosp, Reg Adult Cyst Fibrosis Unit, Liverpool L14 3PE, Merseyside, England
关键词
LEVEL FLUOROQUINOLONE RESISTANCE; EPIDEMIC STRAIN; OXIDATIVE STRESS; SUBTRACTIVE HYBRIDIZATION; HIGH-FREQUENCY; IN-VITRO; SUSCEPTIBILITY; INFECTION; BACTERIOPHAGE; ANTIBIOTICS;
D O I
10.1099/jmm.0.015875-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic respiratory infection by Pseudomonas aeruginosa contributes significantly to the morbidity and mortality associated with cystic fibrosis (CF). Using a series of phenotypic and genotypic tests on collections of 40 isolates per sputum sample, we analysed fluctuations within sputum populations of the P. aeruginosa Liverpool epidemic strain (LES) during pulmonary exacerbations. For each of three patients, three sequential sputum samples were analysed: (1) on presentation with exacerbation at the Regional Adult Cystic Fibrosis Unit, Liverpool; (2) a few days into intravenous antibiotic treatment; (3) when the patient had recovered. Fluctuations were observed in morphotype distribution, the production of virulence-associated quorum-sensing-dependent exoproducts (the phenazine compound pyocyanin and the elastase LasA), antibiotic susceptibility profiles and levels of auxotrophy. PCR assays were used to screen isolates for the presence of novel regions of the LES genome (islands and prophages) and to detect free phages. In one patient there was an increase in the prevalence of the LESGI-5 genomic island during the sampling period from 10 to 97.5% carriage. LES phages 2-4 were detected in either the majority or all sputum samples tested, indicating widespread phage activity during the sampling period. The results of this study are indicative that significant fluctuations occur within P. aeruginosa populations during short periods of pulmonary exacerbation and intravenous antibiotic therapy.
引用
收藏
页码:472 / 481
页数:10
相关论文
共 50 条
  • [21] Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung
    Schobert, Max
    Jahn, Dieter
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (08) : 549 - 556
  • [22] Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections
    Behrends, V.
    Ryall, B.
    Zlosnik, J. E. A.
    Speert, D. P.
    Bundy, J. G.
    Williams, H. D.
    ENVIRONMENTAL MICROBIOLOGY, 2013, 15 (02) : 398 - 408
  • [23] Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
    Workentine, Matthew L.
    Sibley, Christopher D.
    Glezerson, Bryan
    Purighalla, Swathi
    Norgaard-Gron, Jens C.
    Parkins, Michael D.
    Rabin, Harvey R.
    Surette, Michael G.
    PLOS ONE, 2013, 8 (04):
  • [24] PHENOTYPIC CHANGES IN PSEUDOMONAS AERUGINOSA (PSA) POPULATIONS DURING EXACERBATIONS IN ADULT CYSTIC FIBROSIS PATIENTS INFECTED WITH NON-EPIDEMIC STRAINS
    Ashish, A.
    Fothergill, J.
    Mowat, E.
    Gautam, M.
    Winstanley, C.
    Walshaw, M.
    THORAX, 2010, 65 : A123 - A123
  • [25] Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis
    Mayer-Hamblett, Nicole
    Ramsey, Bonnie W.
    Kulasekara, Hemantha D.
    Wolter, Daniel J.
    Houston, Laura S.
    Pope, Christopher E.
    Kulasekara, Bridget R.
    Armbruster, Catherine R.
    Burns, Jane L.
    Retsch-Bogart, George
    Rosenfeld, Margaret
    Gibson, Ronald L.
    Miller, Samuel I.
    Khan, Umer
    Hoffman, Lucas R.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (05) : 624 - 631
  • [26] Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres
    Kidd, Timothy J.
    Ramsay, Kay A.
    Hu, Honghua
    Marks, Guy B.
    Wainwright, Claire E.
    Bye, Peter T.
    Elkins, Mark R.
    Robinson, Philip J.
    Rose, Barbara R.
    Wilson, John W.
    Grimwood, Keith
    Bell, Scott C.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1091 - 1100
  • [27] Instantaneous Within-Patient Diversity of Pseudomonas aeruginosa Quorum-Sensing Populations from Cystic Fibrosis Lung Infections
    Wilder, Cara N.
    Allada, Gopal
    Schuster, Martin
    INFECTION AND IMMUNITY, 2009, 77 (12) : 5631 - 5639
  • [28] Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
    Jackson, Lindsay
    DePas, William
    Morris, Amanda J.
    Guttman, Kevin
    Yau, Yvonne C. W.
    Waters, Valerie
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (161): : 1 - 11
  • [29] Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations In cystic fibrosis patients
    Vic, P
    Ategbo, S
    Turck, D
    Husson, MO
    Tassin, E
    Loeuille, GA
    Deschildre, A
    Druon, D
    Elian, JC
    ArrouetLagandre, C
    Farriaux, JP
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (11) : 948 - 953
  • [30] ELEVATED EXOENZYME EXPRESSION BY PSEUDOMONAS-AERUGINOSA IS CORRELATED WITH EXACERBATIONS OF LUNG-DISEASE IN CYSTIC-FIBROSIS
    GRIMWOOD, K
    SEMPLE, RA
    RABIN, HR
    SOKOL, PA
    WOODS, DE
    PEDIATRIC PULMONOLOGY, 1993, 15 (03) : 135 - 139